Overview

Innova Biosciences are world leading experts in easy-to-use, cutting-edge bioconjugation technologies and services. We have the flexibility to support scientists from academia through to commercial manufacturing, developing and supplying reagent products to make science easier, both off-the shelf and to customer specification.

Our products are based on our antibody and protein labeling, oligonucleotide labeling, particle and phosphate detection enzyme assay technologies.

All of our product ranges are of the highest quality and are designed to streamline R&D and manufacturing processes, whilst also reducing overall project costs by cutting costs associated with e.g. material waste, QC failures, in-house equipment, and staff time, providing increased return on investment compared to traditional methods.

Our ever expanding portfolio, including the Lightning-Link®, InnovaCoat® and Thunder-Link® brands, is available to research laboratories, pharmaceutical, biotechnology and diagnostic companies worldwide.

Following recent acquisition by SYGNIS AG, Innova Biosciences is now part of the SYGNIS group of companies which also includes Expedeon Holdings Ltd. and CBS Scientific. The group is multinational with laboratories and manufacturing facilities in the UK, USA, Spain, Germany and Singapore.

The group develops, manufactures and supplies value-added, easy-to-use, reliable products for use across sample preparation, purification, characterization, conjugation and validation.